Cited by 208T-cell and B-cell ImmunologyCorneal surgery and disordersTransplantation: Methods and Outcomes

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts

Open access

Hori, Junko, Wang, Mingcong, Miyashita, Megumi, Tanemoto, Keiko, Takahashi, Hiroshi, Takemori, Toshitada, Okumura, Ko, Yagita, Hideo, Azuma, Miyuki·2006·The Journal of Immunology

DOI 10.4049/jimmunol.177.9.5928

Open this paper in CoChat — free account Open PDF

Abstract

The programmed death-1 (PD-1) costimulatory pathway has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. We investigated the role of this pathway in establishing an immune privilege status of corneal allografts in mice. B7-H1, but not B7-DC or PD-1, was expressed constitutively in the eye, i.e., cornea, iris-ciliary body, and retina. After corneal allografting, PD-1+CD4+ T cells infiltrated and adhered with B7-H1+ corneal endothelium. Blockade of PD-1 or B7-H1, but not B7-DC, led to accelerated corneal allograft rejection. In B7-H1-expressing corneal allografts, apoptosis of the infiltrating PD-1+CD4+ or CD8+ T cells was observed, after which there was allograft acceptance. In contrast, B7-H1 blockade suppressed apoptosis of infiltrating PD-1+ T cells, which led to allograft rejection. In vitro, destruction of corneal endothelial cells by alloreactive T cells was enhanced when the cornea was pretreated with anti-B7-H1 Ab. This is the first demonstration that the constitutive expression of B7-H1 plays a critical role in corneal allograft survival. B7-H1 expressed on corneal endothelial cells maintains long-term acceptance of the corneal allografts by inducing apoptosis of effector T cells within the cornea.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.4049/jimmunol.177.9.5928

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,259
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 1,990
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
The B7–CD28 superfamily
Sharpe, A. H., & Freeman, G. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri727 · Cited by 1,759
Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.
Medawar, P. B. (1948) · PubMed · Cited by 1,084

Flagged first, then by citations

Show all 58 references

Research works printed but not linked: 55

1993, Ophthalmology, 1728
1992, Ophthalmology, 403
1990, Surv. Ophthalmol., 325
1992, Transplantation, 694
1985, Invest. Ophthalmol. Vis. Sci., 23
1993, J. Immunol., 1727
1987, FASEB J., 199
1990, Adv. Immunol., 191
1977, J. Immunol., 809
2003, Nat. Rev. Immunol., 879
2002, J. Leukocyte Biol., 946
1989, Reg. Immunol., 42
1998, Invest. Ophthalmol. Vis. Sci., 1372
1992, Eur. J. Immunol., 165
2000, Biochem. Biophys. Res. Commun., 257
1998, J. Immunol., 5693
1995, J. Clin. Invest., 82
2000, Invest. Ophthalmol. Vis. Sci., 4195
2000, Br. J. Ophthalmol., 1130
1948, Br. J. Exp. Path., 58
1977, Adv. Immunol., 1
1979, Nature, 326
2005, Stem Cells, 507
2002, Invest. Ophthalmol. Vis. Sci., 639
1984, Invest. Ophthalmol. Vis. Sci., 519
1987, Invest. Ophthalmol. Vis. Sci., 1383
1986, Transplantation, 248
1995, Science, 1189
1997, J. Clin. Invest., 396
2000, Invest. Ophthalmol. Vis. Sci., 443
2000, Invest. Ophthalmol. Vis. Sci., 3032
1992, EMBO J., 3887
1999, Immunity, 141
2002, Nat. Rev. Immunol., 116
1999, Nat. Med., 1365
2001, J. Exp. Med., 839
2000, J. Exp. Med., 1027
2001, Nat. Immunol., 261
2002, Nat. Med., 793
2003, Eur. J. Immunol., 2773
2005, J. Immunol., 1586
2001, Invest. Ophthalmol. Vis. Sci., 720
1997, Eur. J. Immunol., 2490
2001, Invest. Ophthalmol. Vis. Sci., 1820
2004, Immunity, 327
2004, Hepatology, 1312
2001, Science, 319
2003, J. Exp. Med., 71
2003, J. Exp. Med., 63
2001, Blood, 1809
2003, J. Immunol., 4156
2004, J. Clin. Invest., 694
2002, Nat. Med., 787
1999, Transplantation, 1790
1993, Invest. Ophthalmol. Vis. Sci., 3579

Sorted by citations

PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,559
Emerging Concepts in the Immunopathogenesis of AIDS
Douek, D. C., Roederer, M., & Koup, R. A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123549 · Cited by 633
The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
Bardhan, K., Anagnostou, T., & Boussiotis, V. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00550 · Cited by 606
A critical role of IFNγ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1
Sheng, H., Wang, Y., Jin, Y., Zhang, Q., Zhang, Y., Wang, L., Shen, B., Yin, S., Liu, W., Cui, L., et al. (2008) · Cell Research · doi:10.1038/cr.2008.80 · Cited by 390
Dry Eye as a Mucosal Autoimmune Disease
Stern, M. E., Schaumburg, C. S., & Pflugfelder, S. C. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.748052 · Cited by 344
Hair follicle immune privilege and its collapse in alopecia areata
Bertolini, M., McElwee, K. J., Gilhar, A., Bulfone‐Paus, S., & Paus, R. (2020) · Experimental Dermatology · doi:10.1111/exd.14155 · Cited by 348
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
Zhang, Y., Zhou, Y., Lou, J., Li, J., Bo, L., Zhu, K., Wan, X., Deng, X., & Cai, Z. (2010) · Critical Care · doi:10.1186/cc9354 · Cited by 310
Role of PD-1 in Regulating T-Cell Immunity
Jin, H., Ahmed, R., & Okazaki, T. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_116 · Cited by 310
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Xu-Monette, Z. Y., Zhang, M., Li, J., & Young, K. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01597 · Cited by 297
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Gianchecchi, E., Delfino, D. V., & Fierabracci, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.003 · Cited by 277
PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction
Abiko, K., Mandai, M., Hamanishi, J., Yoshioka, Y., Matsumura, N., Baba, T., Yamaguchi, K. D., Murakami, R., Yamamoto, A., Kharma, B., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2199 · Cited by 225
Inducible Expression of B7-H1 (PD-L1) and Its Selective Role in Tumor Site Immune Modulation
Sanmamed, M. F., & Chen, L. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000061 · Cited by 186
FcγR-Binding Is an Important Functional Attribute for Immune Checkpoint Antibodies in Cancer Immunotherapy
Chen, X., Song, X., Li, K., & Zhang, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00292 · Cited by 179
Immunological homeostasis of the eye
Mochizuki, M., Sugita, S., & Kamoi, K. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.10.002 · Cited by 178
Ocular Immune Privilege and Transplantation
Taylor, A. W. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00037 · Cited by 173
SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection
Petrovas, C., Price, D. A., Mattapallil, J. J., Ambrozak, D. R., Geldmacher, C., Cecchinato, V., Vaccari, M., Tryniszewska, E. A., Emma Gostick, D., Roederer, M., et al. (2007) · Blood · doi:10.1182/blood-2007-01-069112 · Cited by 172
The Kynurenine Pathway is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy
Routy, J., Routy, B., Graziani, G. M., & Mehraj, V. (2016) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s38355 · Cited by 171
Immune privilege in corneal transplantation
Hori, J., Yamaguchi, T., Keino, H., Hamrah, P., & Maruyama, K. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.04.002 · Cited by 173
Self-citation
Immune Privilege and Eye-Derived T-Regulatory Cells
Keino, H., Horie, S., & Sugita, S. (2018) · Journal of Immunology Research · doi:10.1155/2018/1679197 · Cited by 165
Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non–Small Cell Lung Carcinoma
Parra, E. R., Villalobos, P. A., Mino, B., & Rodriguez‐Canales, J. (2017) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000531 · Cited by 157
Autoimmunity at the ocular surface: pathogenesis and regulation
Stern, M. E., Schaumburg, C. S., Dana, R., Calonge, M., Niederkorn, J. Y., & Pflugfelder, S. C. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.26 · Cited by 157
Limbal stem cells: identity, developmental origin, and therapeutic potential
González, G., Sasamoto, Y., Ksander, B. R., Frank, M. H., & Frank, N. Y. (2017) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.303 · Cited by 137
Alloimmunity and Tolerance in Corneal Transplantation
Amouzegar, A., Chauhan, S. K., & Dana, R. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600251 · Cited by 129
Regulatory Dendritic Cell Infusion Prolongs Kidney Allograft Survival in Nonhuman Primates
Ezzelarab, M. B., Zahorchak, A. F., Lu, L., Morelli, A. E., Chalasani, G., Demetris, A. J., Lakkis, F. G., Wijkstrom, M. N., Murase, N., Humar, A., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12310 · Cited by 130
Role of PD-L1 and PD-L2 in allergic diseases and asthma
Singh, A. K., Stock, P., & Akbari, O. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02458.x · Cited by 122
Corneal Transplantation and Immune Privilege
Niederkorn, J. Y. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.737877 · Cited by 118
The Function of Donor versus Recipient Programmed Death-Ligand 1 in Corneal Allograft Survival
Shen, L., Jin, Y., Freeman, G. J., Sharpe, A. H., & Dana, M. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3672 · Cited by 117
Immune escape mechanisms of intraocular tumors
Niederkorn, J. Y. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.002 · Cited by 111
Immune Privilege of Corneal Allografts
Niederkorn, J. Y., & Larkin, F. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2010.486100 · Cited by 102
The immunoinhibitory B7-H1 molecule as a potential target in cancer
Dermime, S., & Afreen, S. (2014) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2013.09.005 · Cited by 103
Immune regulation and the eye.
Stein-Streilein, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.08.002 · Cited by 99
Detrimental Contribution of the Immuno-Inhibitor B7-H1 to Rabies Virus Encephalitis
Lafon, M., Mégret, F., Meuth, S. G., Simon, O. J., Velandia-Romero, M. L., Lafage, M., Chen, L., Alexopoulou, L., Flavell, R. A., Prehaud, C. J. N., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7506 · Cited by 98
Graft failure IV. Immunologic mechanisms of corneal transplant rejection
Chong, E.-M., & Dana, M. R. (2007) · International Ophthalmology · doi:10.1007/s10792-007-9099-9 · Cited by 96
The complex role of B7 molecules in tumor immunology
Seliger, B., Marincola, F. M., Ferrone, S., & Abken, H. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.010 · Cited by 93
T-Cell Suppression by Programmed Cell Death 1 Ligand 1 on Retinal Pigment Epithelium during Inflammatory Conditions
Sugita, S., Usui, Y., Horie, S., Futagami, Y., Aburatani, H., Okazaki, T., Honjo, T., Takeuchi, M., & Mochizuki, M. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2846 · Cited by 89
Costimulatory Pathways in Multiple Sclerosis: Distinctive Expression of PD-1 and PD-L1 in Patients with Different Patterns of Disease
Trabattoni, D., Saresella, M., Pacei, M., Marventano, I., Mendozzi, L., Rovaris, M., Caputo, D., Borelli, M., & Clerici, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901038 · Cited by 93
PD-L1 Expression on Human Ocular Cells and Its Possible Role in Regulating Immune-Mediated Ocular Inflammation
Yang, W., Li, H., Chen, P. W., ALIZADEH, H. M., He, Y.-G., Hogan, R. N., & Niederkorn, J. Y. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2397 · Cited by 89
PD-1 as an Immune Modulatory Receptor
Yao, S., & Chen, L. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000060 · Cited by 85
Severing Corneal Nerves in One Eye Induces Sympathetic Loss of Immune Privilege and Promotes Rejection of Future Corneal Allografts Placed in Either Eye
Paunicka, K., Mellon, J., Robertson, D., Petroll, W. M., Brown, J. R., & Niederkorn, J. Y. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13240 · Cited by 81
Interaction of Programmed Death-1 and Programmed Death-1 Ligand-1 Contributes to Testicular Immune Privilege
Cheng, X., Dai, H., Ni, W., Moore, Y., Vankayalapati, R., & Dai, Z. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a75633 · Cited by 83
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Wessely, A., Steeb, T., Erdmann, M., Heinzerling, L., Vera, J., Schlaak, M. S., Berking, C., & Heppt, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030879 · Cited by 80
Ocular Immune Privilege and Ocular Melanoma: Parallel Universes or Immunological Plagiarism?
Niederkorn, J. Y. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00148 · Cited by 77
News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors
Melaiu, O., Lucarini, V., Giovannoni, R., Fruci, D., & Gemignani, F. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.07.001 · Cited by 76
History and Physiology of Immune Privilege
Niederkorn, J. Y., & Stein‐Streilein, J. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273940903564766 · Cited by 74
Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells
Wang, C., Yi, T., Qin, L., Maldonado, R., von Andrian, U. H., Kulkarni, S., Tellides, G., & Pober, J. S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66204 · Cited by 74
Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy
Taglauer, E. S., Yankee, T. M., & Petroff, M. G. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2008.12.001 · Cited by 72
Mechanistic insights into immunomodulation by hepatic stellate cells in mice: A critical role of interferon‐γ signaling†
Yang, H., Chou, H., Gu, X., Wang, L., Brown, K. E., Fung, J. J., Lu, L., & Qian, S. (2009) · Hepatology · doi:10.1002/hep.23202 · Cited by 71
Programmed Death-1/B7-H1 Negative Costimulation Protects Mouse Liver Against Ischemia and Reperfusion Injury
Ji, H., Shen, X., GAO, F. G., Ke, B., Freitas, M. C. S., Uchida, Y., Busuttil, R. W., Zhai, Y., & Kupiec‐Weglinski, J. W. (2010) · Hepatology · doi:10.1002/hep.23843 · Cited by 71
Human Corneal Endothelial Cells Expressing Programmed Death-Ligand 1 (PD-L1) Suppress PD-1 + T Helper 1 Cells by a Contact-Dependent Mechanism
Sugita, S., Usui, Y., Horie, S., Futagami, Y., Yamada, Y., Ma, J., Kezuka, T., Hamada, H., Usui, T., Mochizuki, M., et al. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2536 · Cited by 68
Matching for Human Leukocyte Antigens (HLA) in corneal transplantation – To do or not to do
van Essen, T. H., Roelen, D. L., Williams, K. A., & Jager, M. J. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.01.001 · Cited by 65
Mouse Sertoli Cells Display Phenotypical and Functional Traits of Antigen-Presenting Cells in Response to Interferon Gamma
Secco, V. D., Riccioli, A., Padula, F., Ziparo, E., & Filippini, A. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.063578 · Cited by 65
Review of Ocular Immune Privilege in the Year 2010: Modifying the Immune Privilege of the Eye
Hori, J., Vega, J. L., & Masli, S. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2010.512696 · Cited by 64
Self-citation
Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation
Wang, X., Wang, T., Lam, E., Álvarez, D., & Sun, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512090 · Cited by 71
Functional expression of B7H1 on retinal pigment epithelial cells
Usui, Y., Okunuki, Y., Hattori, T., Kezuka, T., Keino, H., Ebihara, N., Sugita, S., Usui, M., Gotô, H., & Takeuchi, M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.09.007 · Cited by 65
Hair Follicle Mesenchyme-Associated PD-L1 Regulates T-Cell Activation Induced Apoptosis: A Potential Mechanism of Immune Privilege
Wang, X., Marr, A. K., Breitkopf, T., Leung, G., Hao, J., Wang, E., Kwong, N., Akhoundsadegh, N., Chen, L., Mui, A., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.368 · Cited by 62
The immunology of corneal xenotransplantation: a review of the literature
Hara, H., & Cooper, D. K. C. (2010) · Xenotransplantation · doi:10.1111/j.1399-3089.2010.00608.x · Cited by 60
Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation
Hori, J. (2008) · Journal of ocular biology, diseases, and informatics · doi:10.1007/s12177-008-9010-6 · Cited by 59
Self-citation
A Novel Function for Programmed Death Ligand-1
Jin, Y., Chauhan, S. K., Annan, J. E., Sage, P. T., Sharpe, A. H., & Dana, R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.027 · Cited by 58
Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage
Fuchsluger, T. M. A., Jurkunas, U. V., Kazlauskas, A., & Dana, R. (2011) · Gene Therapy · doi:10.1038/gt.2011.20 · Cited by 57
A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease
Saresella, M., Calabrese, E., Marventano, I., Piancone, F., Gatti, A. V., Farina, E., Alberoni, M., & Clerici, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.004 · Cited by 58
Immune barriers to successful gene therapy
Wu, T.-L., & Ertl, H. C. J. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.11.005 · Cited by 55
Mechanisms of Immune Privilege in the Posterior Eye
Stein‐Streilein, J. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.740535 · Cited by 60
Dickkopf-3, a Tissue-Derived Modulator of Local T-Cell Responses
Meister, M. T., Papatriantafyllou, M., Nordström, V., Kumar, V., Ludwig, J., Lui, K. O., Boyd, A. S., Popović, Z. V., Fleming, T. H., Moldenhauer, G., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00078 · Cited by 52
Cornea: Window to Ocular Immunology
Niederkorn, J. Y. (2011) · Current Immunology Reviews · doi:10.2174/157339511796196593 · Cited by 50
GITR Ligand–Mediated Local Expansion of Regulatory T Cells and Immune Privilege of Corneal Allografts
Hori, J., Taniguchi, H., Wang, M., Oshima, M., & Azuma, M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4959 · Cited by 49
Self-citation
Influence of PD ‐ L 1 cross‐linking on cell death in PD ‐ L 1‐expressing cell lines and bovine lymphocytes
Ikebuchi, R., Konnai, S., Okagawa, T., Yokoyama, K., Nakajima, C., Suzuki, Y., Murata, S., & Ohashi, K. (2014) · Immunology · doi:10.1111/imm.12243 · Cited by 46
Mechanism and potential predictive biomarkers of immune checkpoint inhibitors in NSCLC
Qu, J., Jiang, M., Wang, L., Zhao, D., Qin, K., Wang, Y., Tao, J., & Zhang, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109996 · Cited by 46
Constitutive Neuronal Expression of the Immune Regulator, Programmed Death 1 (PD-1), Identified During Experimental Autoimmune Uveitis
Ling, C., Pai, V., Levinson, R. D., Sharpe, A. H., Freeman, G. J., Braun, J. G., & Gordon, L. K. (2009) · Ocular Immunology and Inflammation · doi:10.1080/09273940802491884 · Cited by 46
Galectin-9-Mediated Protection from Allo-Specific T Cells as a Mechanism of Immune Privilege of Corneal Allografts
Shimmura-Tomita, M., Wang, M., Taniguchi, H., Akiba, H., Yagita∥, H., & Hori, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063620 · Cited by 44
Self-citation
Glial Cell Expression of PD-L1
Chauhan, P., & Lokensgard, J. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071677 · Cited by 41
Fetomaternal Immune Tolerance: Crucial Mechanisms of Tolerance for Successful Pregnancy in Humans
Yousefzadeh, Y., Soltani‐Zangbar, M. S., Hemmatzadeh, M., Shomali, N., Mahmoodpoor, A., Heris, J. A., & Yousefi, M. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1909061 · Cited by 43
B7-H3 and its relevance in cancer immunological and non-immunological perspectives
Nygren, M. K. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e304 · Cited by 43
Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation
Ueki, S., Castellaneta, A., Yoshida, O., Ozaki¹, K. S., Zhang, M. M., Kimura, S., Isse, K., Ross, M., Shao, L., Stolz, D. B., et al. (2011) · Hepatology · doi:10.1002/hep.24360 · Cited by 43
Keratinocyte-Associated B7-H1 Directly Regulates Cutaneous Effector CD8+ T Cell Responses
Ritprajak, P., Hashiguchi, M., Tsushima, F., Chalermsarp, N., & Azuma, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902478 · Cited by 43
Self-citation
The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer
Henick, B. S., Herbst, R. S., & Goldberg, S. B. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.955794 · Cited by 41
Immune Checkpoints Contribute Corneal Immune Privilege: Implications for Dry Eye Associated with Checkpoint Inhibitors
Hori, J., Kunishige, T., & Nakano, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113962 · Cited by 46
Self-citation
Costimulator B7-DC Attenuates Strong Th2 Responses Induced by Nippostrongylus brasiliensis
Ishiwata, K., Watanabe, N., Guo, M., Tomihara, K., Brumlik, M. J., Yagita∥, H., Pardoll, D. M., Chen, L., & Shin, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0804051 · Cited by 42
Self-citation
Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance
Wang, Y., Zhuang, Q., Zhou, S., Hu, Z., & Lan, R. (2009) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-009-0116-2 · Cited by 41
High-risk corneal allografts: A therapeutic challenge
Tian, Y., Rajendran, V., Griffith, M., Forrester, J. V., & Kuffová, L. (2016) · World Journal of Transplantation · doi:10.5500/wjt.v6.i1.10 · Cited by 40
Immune Checkpoint Inhibitors in Uveal and Conjunctival Melanoma
Wierenga, A. P. A., Cao, J., Luyten, G. P. M., & Jager, M. J. (2019) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000263 · Cited by 40
Immune modulation in corneal transplantation
Fu, H., Larkin, F., & George, A. J. T. (2008) · Transplantation Reviews · doi:10.1016/j.trre.2007.12.005 · Cited by 40
CTL Induction of Tumoricidal Nitric Oxide Production by Intratumoral Macrophages Is Critical for Tumor Elimination
Miguel, R. D. V., Cherpes, T. L., Watson, L. J., & McKenna, K. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903411 · Cited by 39
Therapeutic targeting of B7-H1 in breast cancer
Hasan, A., Ghebeh, H., Lehé, C. L., Ahmad, R., & Dermime, S. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.613826 · Cited by 39
Role of Lentivirus-Mediated Overexpression of Programmed Death-Ligand 1 on Corneal Allograft Survival
Nosov, M., Wilk, M. M., Morcos, M., Cregg, M., O’Flynn, L., Treacy, O., & Ritter, T. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03948.x · Cited by 39
PD-L1hi retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells
Yan, K., Sun, D., Jiang, G., Kaplan, H. J., & Shao, H. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610332 · Cited by 38
Immunoregulation on the Ocular Surface: 2nd Cullen Symposium
Pflugfelder, S. C., & Stern, M. E. (2009) · The Ocular Surface · doi:10.1016/s1542-0124(12)70297-5 · Cited by 37
The roles of the PD ‐1/ PD ‐L1 pathway at immunologically privileged sites
Wang, L., Li, Z., Hu, X., Muyayalo, K. P., Zhang, Y., & Liao, A. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12710 · Cited by 36
Influence of Immune Privilege on Ocular Tumor Development
McKenna, K. C., & Chen, P. W. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273941003669950 · Cited by 38
The Eye Sees Eye to Eye With the Immune System: The 2019 Proctor Lecture
Niederkorn, J. Y. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-28632 · Cited by 35
Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma
Wang, W., Lam, W., & Chen, L. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2260-7 · Cited by 34
The STATus of PD‐L1 (B7‐H1) on tolerogenic APCs
Sumpter, T. L., & Thomson, A. W. (2011) · European Journal of Immunology · doi:10.1002/eji.201041353 · Cited by 33
PD‐1 signalling in CD4+ T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide‐induced tolerance
Konkel, J. E., Frommer, F., Leech, M. D., Yagita∥, H., Waisman, A., & Anderton, S. M. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03216.x · Cited by 33
Self-citation
Mechanisms of Maternal Immune Tolerance During Pregnancy
John, E., Jorge, M., Jonathan, W., Ea, V. L., & Smith, R. (2012) · InTech eBooks · doi:10.5772/33541 · Cited by 32
The application of nano-medicine to overcome the challenges related to immune checkpoint blockades in cancer immunotherapy: Recent advances and opportunities
Sanaei, M., Pourbagheri‐Sigaroodi, A., Kaveh, V., Sheikholeslami, S. A., Salari, S., & Bashash, D. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103160 · Cited by 34
Novel strategies to eliminate persistent viral infections
Martinic, M. M. A., & von Herrath, M. G. (2008) · Trends in Immunology · doi:10.1016/j.it.2007.12.002 · Cited by 32
PD-L1/B7-H1 Inhibits Viral Clearance by Macrophages in HSV-1–Infected Corneas
Jeon, S., Rowe, A. M., Carroll, K. L., Harvey, S. A. K., & Hendricks, R. L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700417 · Cited by 31
Immune Privilege of Stem Cells
Ichiryu, N., & Fairchild, P. J. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-478-4_1 · Cited by 29
Functional Tolerance of CD8+ T Cells Induced by Muscle-Specific Antigen Expression
Calbo, S., Delagreverie, H. M., Arnoult, C., Authier, F., Tron, F., & Boyer, O. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.408 · Cited by 32

Authors: Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., Okumura, K., Yagita, H., & Azuma, M.
Affiliations: Nippon Medical School (JP)
National Institute of Infectious Diseases (JP)
Juntendo University (JP)
Department of Immunology, Juntendo University School of Medicine , Tokyo ,
Tokyo Medical and Dental University (JP)
ORCID: Hori, Junko
Takahashi, Hiroshi
Okumura, Ko
Azuma, Miyuki
Venue: The Journal of Immunology
Publisher: Oxford University Press (OUP)
Published: 2006-11-01
Volume: 177
Issue: 9
Pages: 5928-5935
ISSN: 0022-1767 (ISSN-L)
1550-6606
DOI: 10.4049/jimmunol.177.9.5928
OpenAlex: W2150372796
Cited by: 208
References: 58
Citations by year: 2026: 1 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 11 · 2020: 16 · 2019: 8 · 2018: 10 · 2017: 8 · 2016: 12 · 2015: 10 · 2014: 7 · 2013: 18 · 2012: 7
FWCI: 5.76
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: The Journal of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Ophthalmology › Corneal surgery and disorders
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords: PD-L1, PD-1, immune privilege, corneal allograft, corneal endothelium, T cell apoptosis, allograft rejection, costimulatory molecules, PD-L2, CD4+ T cells, CD8+ T cells
MeSH terms: Animals, Antibodies, Monoclonal, Antigens, Surface, Cornea, Graft Rejection, Graft Survival, Male, Membrane Glycoproteins, Mice, Inbred Strains, Peptides, Transplantation, Homologous, CD4-Positive T-Lymphocytes, Corneal Transplantation, Apoptosis, B7-1 Antigen, CD8-Positive T-Lymphocytes, Endothelial Cells, Apoptosis Regulatory Proteins, Mice, B7-H1 Antigen, Programmed Cell Death 1 Receptor, Programmed Cell Death 1 Ligand 2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks